Bronchiolitis.
Lozano
Juan Manuel
JM
Department of Paediatrics and Clinical Epidemiology Unit, School of Medicine, Javeriana University, Bogotá DC, Colombia.
D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D001988:Bronchiolitis / Q000188:drug therapy* / Q000517:prevention & control; D001993:Bronchodilator Agents / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D003428:Cross Infection / Q000517:prevention & control; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D000069455:Palivizumab; D012136:Respiratory Syncytial Viruses / Q000276:immunology; D012254:Ribavirin / Q000009:adverse effects / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D001993:Bronchodilator Agents; D016756:Immunoglobulins, Intravenous; C098685:respiratory syncytial virus immune globulin intravenous; D012254:Ribavirin; D000069455:Palivizumab